Karmali, Priya P.
Arcturus Therapeutics (United States)
5 papers on CoChat
Most cited papers
- Verified
Systemic delivery of factor IX messenger RNA for protein replacement therapy
Ramaswamy, S., Tonnu, N., Tachikawa, K., Limphong, P., Vega, J. B., Karmali, P. P., Chivukula, P., & Verma, I. M. (2017) · Proceedings of the National Academy of Sciences
Hemophilia Treatment and ResearchRNA Interference and Gene Delivery
Cited by 301
- Verified
Targeting atherosclerosis by using modular, multifunctional micelles
Peters, D., Kastantin, M., Kotamraju, V. R., Karmali, P. P., Gujraty, K., Tirrell, M., & Ruoslahti, E. (2009) · Proceedings of the National Academy of Sciences
Nanoparticle-Based Drug DeliveryAtherosclerosis and Cardiovascular Diseases
Cited by 271
- Verified
A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice
de Alwis, R., Gan, E. S., Chen, S., Leong, Y. S., Tan, H. C., Zhang, S. L., Yau, C., Low, J. G. H., Kalimuddin, S., Matsuda, D., et al. (2021) · Molecular Therapy
SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies
Cited by 191
- Verified
Different effect of hydrogelation on antifouling and circulation properties of dextran-iron oxide nanoparticles
Karmali, P. P., Chao, Y., Park, J.-H., Sailor, M. J., Ruoslahti, E., Esener, S. C., & Simberg, D. (2012) · Molecular Pharmaceutics
Nanoparticle-Based Drug DeliveryCharacterization and Applications of Magnetic Nanoparticles
Cited by 36
- Verified
Liver lipopolysaccharide binding protein prevents hepatic inflammation in physiological and pathological non-obesogenic conditions
Milbank, E., Díaz-Trelles, R., Dragano, N., Latorre, J., Mukthavaram, R., Mayneris-Perxachs, J., Ortega, F., Federici, M., Burcelin, R., Karmali, P. P., et al. (2023) · Pharmacological Research
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 26
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free